Literature DB >> 28525830

Outpatient management of pulmonary embolism.

P-M Roy1, T Moumneh2, A Penaloza3, O Sanchez4.   

Abstract

Despite clear potential benefits of outpatient care, most patients suffering from pulmonary embolism (PE) are currently hospitalized due to the fear of possible adverse events. Nevertheless, some teams have increased or envisage to increase outpatient treatment or early discharge. We performed a narrative systematic review of studies published on this topic. We identified three meta-analyses and 23 studies, which involved 3671 patients managed at home (n=3036) or discharged early (n=535). Two main different approaches were applied to select patients eligible for outpatient in recent prospective studies, one based on a list of pragmatic criteria as the HESTIA rule, the other adding severity criteria (i.e. risk of death) as the Pulmonary Embolism Severity Criteria (PESI) or simplified PESI. In all these studies, a specific follow-up was performed for patients managed at home involving a dedicated team. The overall early (i.e. between 1 to 3 months) complication rate was low, <2% for thromboembolic recurrences or major bleedings and <3% for deaths with no evidence in favour of one selection strategy or another. Outpatient management appears to be feasible and safe for many patients with PE. In the coming years, outpatient treatment may be considered as the first line management for hemodynamically stable PE patients, subject to the respect of simple eligibility criteria and on the condition that a specific procedure for outpatient care is developed in advance.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hospitalization; Outpatient treatment; Pulmonary embolism; Systematic review

Mesh:

Year:  2017        PMID: 28525830     DOI: 10.1016/j.thromres.2017.05.001

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  13 in total

Review 1.  "Outpatient Management" of Pulmonary Embolism Defined in the Primary Literature: A Narrative Review.

Authors:  Judy Shan; Dayna J Isaacs; Harjot Bath; Elizabeth J Johnson; Dani Julien; David R Vinson
Journal:  Perm J       Date:  2021-07-28

Review 2.  Outpatient versus inpatient treatment for acute pulmonary embolism.

Authors:  Hugo Hb Yoo; Vania Santos Nunes-Nogueira; Paulo J Fortes Villas Boas; Cathryn Broderick
Journal:  Cochrane Database Syst Rev       Date:  2022-05-05

3.  Outpatient versus inpatient treatment for acute pulmonary embolism.

Authors:  Hugo Hb Yoo; Vania Santos Nunes-Nogueira; Paulo J Fortes Villas Boas; Cathryn Broderick
Journal:  Cochrane Database Syst Rev       Date:  2019-03-06

4.  Efficacy and safety of outpatient treatment with direct oral anticoagulation in pulmonary embolism.

Authors:  R Ghazvinian; A Gottsäter; J L Elf
Journal:  J Thromb Thrombolysis       Date:  2018-02       Impact factor: 2.300

5.  Emergency Department Patient Satisfaction with Treatment of Low-risk Pulmonary Embolism.

Authors:  Laura E Simon; Hilary R Iskin; Ridhima Vemula; Jie Huang; Adina S Rauchwerger; Mary E Reed; Dustin W Ballard; David R Vinson
Journal:  West J Emerg Med       Date:  2018-10-18

Review 6.  Implementation of an acute DVT ambulatory care pathway in a large urban centre: current challenges and future opportunities.

Authors:  Sarah Kelliher; Patricia Hall; Barry Kevane; Daniela Dinu; Karl Ewins; Peter MacMahon; Fionnuala Ní Áinle; Tomás Breslin
Journal:  Thromb J       Date:  2019-07-10

Review 7.  Reducing the hospital burden associated with the treatment of pulmonary embolism.

Authors:  W Frank Peacock; Adam J Singer
Journal:  J Thromb Haemost       Date:  2019-04-01       Impact factor: 5.824

8.  Comprehensive Outpatient Management of Low-Risk Pulmonary Embolism: Can Primary Care Do This? A Narrative Review.

Authors:  David R Vinson; Drahomir Aujesky; Geert-Jan Geersing; Pierre-Marie Roy
Journal:  Perm J       Date:  2020-03-13

9.  Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting.

Authors:  Huifang Liang; Raghava Danwada; Dianlin Guo; Jeffrey R Curtis; Ryan D Kilpatrick; Barbara Hendrickson; Syed S Islam
Journal:  RMD Open       Date:  2019-09-23

10.  Primary care physicians comprehensively manage acute pulmonary embolism without higher-level-of-care transfer: A report of two cases.

Authors:  Dayna J Isaacs; Elizabeth J Johnson; Erik R Hofmann; Suresh Rangarajan; David R Vinson
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.